Artificial Intelligence
April 23–25, 2018
Boston, MA • United States

2017 Speakers

2017 Keynoters

Robert Bradway

CEO, Amgen

Michael Mahoney

CEO, Boston Scientific

George Barrett

CEO, Cardinal Health

Omar Ishrak, PhD

CEO, Medtronic

Frans van Houten

CEO, Philips

Tony Coles, MD

CEO, Yumanity Therapeutics

Nancy Brown

CEO, American Heart Association

Michael Mussallem

CEO, Edwards Lifesciences

Timothy Ring

CEO, Bard

John Lechleiter, PhD

Chairman, Eli Lilly and Company

Gary Gibbons, MD

Director, NHLBI

John Flannery

CEO, GE Healthcare

Jessica Mega, MD

CMO, Verily

Ora Pescovitz, MD

SVP and US Medical Leader, Eli Lilly and Company

Jonathan Rennert

CEO, Zoll Medical

Michael Minogue

CEO, Abiomed

Stéphane Bancel

CEO, Moderna

Robert Califf, MD

Commissioner (former), Food and Drug Administration

Tamara Syrek Jensen

Director, Coverage and Analysis Group, CMS

David Torchiana, MD

CEO, Partners HealthCare

Elizabeth Nabel, MD

President, Brigham Health

Professor of Medicine, Harvard Medical School

Peter Slavin, MD

President, Massachusetts General Hospital

Paul Fonteyne

CEO, Boehringer Ingelheim USA

Paul LaViolette

Managing Partner & COO, SV Life Sciences Advisers

Michael Jaff, DO

President, Newton-Wellesley Hospital, Partners HealthCare

Professor of Medicine, Harvard Medical School

Jean-François Formela, MD

Partner, Atlas Venture

Joseph Loscalzo, MD, PhD

Chairman, Department of Medicine, Physician-in-Chief, Brigham and Women's Hospital

Hersey Professor of the Theory and Practice of Medicine, Soma Weiss, MD Distinguished Chair in Medicine, Harvard Medical School

Katrina Armstrong, MD

Physician-in-Chief, Department of Medicine, Massachusetts General Hospital

Jackson Professor of Clinical Medicine, Harvard Medical School

Jeff Mirviss

SVP and President, Peripheral Interventions, Boston Scientific

Marc Semigran, MD

CMO, Myokardia

Ludovic Helfgott

Global VP, Cardiovascular, Renal and Metabolism, AstraZeneca

Meg Tirrell

Reporter, CNBC

Susan Dentzer

CEO, Network for Excellence in Health Innovation

Morris Birnbaum, MD, PhD

SVP and CSO, CVMET, Pfizer

Paul Underwood, MD

Medical Director, Boston Scientific

Adele Gulfo

EVP & Head, Global Commercial Development, Mylan

2017 Featured Speakers

Note: speakers are subject to change.